Drugs / SB213503
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00148941 | Jan 2005 → Nov 2006 | diphtheria, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SB213503 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00148941 ↗ |
| Modality | Vaccine | “SB213503 lot 1 vaccine” NCT00148941 ↗ |